BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 26643611)

  • 1. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
    Lee H; Kim Y; Han K; Oh EJ
    Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.
    Bentow C; Rosenblum R; Correia P; Karayev E; Karayev D; Williams D; Kulczycka J; Fritzler MJ; Mahler M
    Lupus; 2016 Jul; 25(8):897-904. PubMed ID: 27252267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases.
    Shovman O; Gilburd B; Chayat C; Amital H; Langevitz P; Watad A; Guy A; Perez D; Azoulay D; Blank M; Segal Y; Bentow C; Mahler M; Shoenfeld Y
    Clin Exp Rheumatol; 2018; 36(1):121-126. PubMed ID: 28770702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort.
    Miyara M; Albesa R; Charuel JL; El Amri M; Fritzler MJ; Ghillani-Dalbin P; Amoura Z; Musset L; Mahler M
    Clin Dev Immunol; 2013; 2013():703759. PubMed ID: 23476678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases].
    Türkoğlu G; Berkem R; Karakoç AE
    Mikrobiyol Bul; 2018 Oct; 52(4):413-424. PubMed ID: 30522426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.
    Mahler M; Hanly JG; Fritzler MJ
    Autoimmun Rev; 2012 Jul; 11(9):642-5. PubMed ID: 22100330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of anti-DFS70 autoantibodies.
    Kang SY; Lee WI; Kim MH; La Jeon Y
    Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Relevance of Anti-DFS70 Autoantibodies.
    Conrad K; Röber N; Andrade LE; Mahler M
    Clin Rev Allergy Immunol; 2017 Apr; 52(2):202-216. PubMed ID: 27350273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
    Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
    J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
    Seelig CA; Bauer O; Seelig HP
    Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls.
    Schmeling H; Mahler M; Levy DM; Moore K; Stevens AM; Wick J; McMillan JD; Horneff G; Assassi S; Charles J; Salazar G; Mayes MD; Silverman ED; Klien-Gitelman M; Lee T; Brunner HI; Reed AM; Fritzler MJ
    J Rheumatol; 2015 Dec; 42(12):2419-26. PubMed ID: 26472409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of anti-dense fine speckled 70 antibodies in healthy individuals and patients with antinuclear antibody-associated autoimmune rheumatic diseases in Japan.
    Hayashi N; Uto K; Imanishi A; Sugiyama D; Morinobu A; Saegusa J
    Medicine (Baltimore); 2021 Mar; 100(9):e24556. PubMed ID: 33655922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
    Yumuk Z; Demir M
    J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.
    Bonroy C; Schouwers S; Berth M; Stubbe M; Piette Y; Hoffman I; Devreese K; Van Hoovels L
    Clin Chem Lab Med; 2018 Jun; 56(7):1090-1099. PubMed ID: 29427547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
    La Jeon Y; Kang SY; Lee WI; Kim MH
    Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New genetically engineered DFS70 knock-out HEp-2 cells enable rapid and specific recognition of anti-DFS70 antibodies.
    Bizzaro N; Fabris M
    Autoimmunity; 2018 Jun; 51(4):152-156. PubMed ID: 29732925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescence.
    Bizzaro N; Tonutti E; Tampoia M; Infantino M; Cucchiaro F; Pesente F; Morozzi G; Fabris M; Villalta D;
    Clin Chim Acta; 2015 Dec; 451(Pt B):271-7. PubMed ID: 26471835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of the dense fine speckled pattern and anti-DFS70 antibodies for the diagnosis of systemic autoimmune rheumatic diseases].
    López Sañudo S; Fernández Alonso I; López Hoyos M
    Med Clin (Barc); 2015 Sep; 145(5):218-23. PubMed ID: 26021571
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases.
    Peker BO; Şener AG; Tarhan EF; Kaya S
    Clin Rheumatol; 2019 Dec; 38(12):3627-3633. PubMed ID: 31396837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-SS-A/Ro antibody determination by indirect immunofluorescence and comparison of different methods of anti-nuclear antibody screening: evaluation of the utility of HEp-2 cells transfected with the 60 kDa SS-A/Ro as a substrate.
    Tanaka N; Muro Y; Sugiura K; Tomita Y
    Mod Rheumatol; 2008; 18(6):585-92. PubMed ID: 18633690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.